Introduction
The publication by Burns et al. on the Levels of Evidence Hierarchy provides a helpful framework for determining the credibility and accuracy of scientific journal articles and other forms of peer-reviewed research. As a doctor, I rely heavily on this hierarchy when making choices that will positively affect my patients’ health. It has had a profound effect on my approach to research evaluation and use, ultimately leading me in the direction of evidence-based medicine.
Article Evaluation
Burns et al.’s (2011) hierarchy, first and foremost, offers a methodical framework for categorizing evidence quality. There are levels I through V, with I being the highest and V the lowest. This categorization considers aspects such as research methodology, sample size, and the presence or absence of bias. Using this grading system, I can critically evaluate journal papers and give more weight to research that provides high-quality evidence.
Systematic reviews and meta-analyses of randomized controlled trials (RCTs) represent level I evidence. Studies like these are notable for their high standards of technique, substantial sample sizes, and low levels of bias. As a doctor, I would put the most stock in Level I evidence when making judgments about patient care (Vaddepally et al., 2020). A meta-analysis of randomized controlled trials (RCTs) that demonstrates a therapy’s effectiveness is more likely to influence my recommendation to patients.
Well-designed randomized controlled trials are examples of Level II evidence. Even if they aren’t quite as rigorous as systematic reviews and meta-analyses, they nonetheless provide substantial evidence. If no systematic reviews are available, I would evaluate Level II evidence to inform clinical choices.
Controlled trials without random assignment, such as cohort studies, are examples of level III evidence. To evaluate causes and long-term effects, research like this is crucial. I may rely on Level III evidence when there is a dearth of evidence at Levels I and II. In the absence of randomized controlled trials (RCTs), I may propose a therapy if the results of high-quality cohort studies are promising.
The quality of the evidence decreases as we go down the scale to Level IV (case-control studies) and Level V (expert opinion). A greater likelihood of bias and lower reliability means this research can’t be relied on to guide clinical practice. However, for uncommon or newly identified illnesses, expert opinion (Level V) may be helpful when more robust evidence is unavailable.
Furthermore, Burns et al.’s (2011) hierarchy underscores the importance of conducting a thorough analysis of the existing research. It prompts doctors to evaluate the reliability, validity, and consistency of results, as well as the possibility of bias (Chen et al., 2019). Utilizing these critical evaluation skills in my work helps me avoid making hasty, uninformed decisions about my patients’ care based solely on the hierarchical level of the data.
In addition, the hierarchy proposed by Burns et al. (2011) reflects the ever-evolving character of evidence-based medicine. It is crucial to examine and change healthcare procedures when new research becomes available. For instance, if I am currently using a therapy that is effective based on Level I evidence, but tomorrow, new Level I evidence arises proposing an even more effective alternative (Clark et al., 2018), I must adjust my practice to reflect this best available evidence.
Conclusion
In conclusion, as a medical practitioner, Burns et al.’s (2011) Levels of Evidence Hierarchy has had a profound effect on the way I evaluate scientific literature and peer-reviewed studies. It offers a methodical approach to determining the reliability and applicability of evidence, which helps in making sound judgments. While I give more weight to more extensive evidence, I do not discount more limited material in its own right. To further evaluate the study’s validity and its relevance to my patients’ situations, I use critical evaluation techniques. By adhering to this hierarchy, I can provide my patients with the most effective treatment possible, as it is based on the most reputable and applicable scientific studies.
References
Burns, P. B., Rohrich, R. J., & Chung, K. C. (2011). The levels of evidence and their role in evidence-based medicine. Plastic and Reconstructive Surgery, 128(1), 305–310.
Chen, Y., Hua, F., Mei, Y., Thiruvenkatachari, B., Riley, P., & He, H. (2019). The characteristics and level of evidence of clinical studies published in 5 leading orthodontic journals. Journal of Evidence Based Dental Practice, 19(3), 273–282.
Clark, E., Draper, J., & Taylor, R. (2018). Healthcare education research: The case for rethinking hierarchies of evidence. Journal of Advanced Nursing, 74(11), 2480–2483.
Vaddepally, R. K., Kharel, P., Pandey, R., Garje, R., & Chandra, A. B. (2020). Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence. Cancers, 12(3), 738.